- Home
- PTGX vs NAVN Comparison
PTGX vs NAVN Comparison
Compare PTGX & NAVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- NAVN
- Stock Information
- Founded
- PTGX 2006
- NAVN 2015
- Country
- PTGX United States
- NAVN United States
- Employees
- PTGX N/A
- NAVN N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- NAVN Computer Software: Prepackaged Software
- Sector
- PTGX Health Care
- NAVN Technology
- Exchange
- PTGX Nasdaq
- NAVN Nasdaq
- Market Cap
- PTGX 5.0B
- NAVN 5.3B
- IPO Year
- PTGX 2016
- NAVN 2025
- Fundamental
- Price
- PTGX $85.30
- NAVN $16.70
- Analyst Decision
- PTGX Strong Buy
- NAVN
- Analyst Count
- PTGX 9
- NAVN 0
- Target Price
- PTGX $86.44
- NAVN N/A
- AVG Volume (30 Days)
- PTGX 912.3K
- NAVN 3.8M
- Earning Date
- PTGX 11-06-2025
- NAVN 11-25-2025
- Dividend Yield
- PTGX N/A
- NAVN N/A
- EPS Growth
- PTGX N/A
- NAVN N/A
- EPS
- PTGX 0.72
- NAVN N/A
- Revenue
- PTGX $209,217,000.00
- NAVN $612,523,000.00
- Revenue This Year
- PTGX N/A
- NAVN N/A
- Revenue Next Year
- PTGX $140.23
- NAVN N/A
- P/E Ratio
- PTGX $117.38
- NAVN N/A
- Revenue Growth
- PTGX N/A
- NAVN 33.46
- 52 Week Low
- PTGX $33.31
- NAVN $16.01
- 52 Week High
- PTGX $93.25
- NAVN $22.75
- Technical
- Relative Strength Index (RSI)
- PTGX 66.16
- NAVN N/A
- Support Level
- PTGX $76.70
- NAVN N/A
- Resistance Level
- PTGX $86.90
- NAVN N/A
- Average True Range (ATR)
- PTGX 3.20
- NAVN 0.00
- MACD
- PTGX 0.30
- NAVN 0.00
- Stochastic Oscillator
- PTGX 83.71
- NAVN 0.00
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.